Neovascular Glaucoma Strongly Linked to Higher Cardiovascular Risk and Mortality
Patients diagnosed with neovascular glaucoma (NVG) face nearly double the risk of cardiovascular events and death compared to those with other eye conditions, according to a large-scale retrospective study published in Scientific Reports. The findings suggest NVG may serve as a marker for severe systemic vascular dysfunction, warranting closer collaboration between eye care providers and cardiologists.
Key Findings: NVG as a Cardiovascular Red Flag
The study analyzed electronic health records of over 34,000 patients with NVG, matched against controls with cataracts—a common but non-systemic eye condition. Researchers found:
- All-cause mortality: 18.37% in NVG patients vs. 9.76% in controls (HR 1.70)
- Myocardial infarction: 8.1% vs. 4.83% (HR 1.53)
- Stroke: 7.51% vs. 4.25% (HR 1.62)
- Cardiac arrest: 3.02% vs. 1.73% (HR 1.57)
- 3P-MACE (combined events): 26.59% vs. 15.68% (HR 1.59)
Even when comparing NVG patients to those with similar retinal diseases (like proliferative diabetic retinopathy), the mortality and cardiovascular risks remained significantly elevated.
Why Does NVG Signal Higher Cardiovascular Risk?
Neovascular glaucoma develops when abnormal blood vessels grow on the iris and retina, often due to retinal ischemia. This process reflects severe vascular compromise, which appears to extend beyond the eye:
- Systemic inflammation: Chronic ocular hypoxia triggers pro-inflammatory pathways that may accelerate atherosclerosis.
- Endothelial dysfunction: Similar pathways that damage retinal blood vessels may impair systemic circulation.
- Shared risk factors: NVG frequently co-occurs with diabetes, hypertension, and vascular diseases that directly increase cardiovascular risk.
“The eye is a window to the body’s vascular health. When we see neovascularization in the retina, it’s often a sign that systemic vascular regulation has already broken down.”
What This Means for Clinicians
1. NVG Should Trigger Systemic Workups
Eye care providers may be the first to identify patients at high cardiovascular risk. The study recommends:
- Screening NVG patients for uncontrolled hypertension, diabetes, and dyslipidemia
- Evaluating for silent cardiovascular disease (e.g., carotid Doppler, EKG)
- Encouraging prompt referral to primary care or cardiology
2. Multidisciplinary Care is Critical
Given the overlapping risks, ophthalmologists and cardiologists should:
- Establish clear communication pathways for high-risk patients
- Coordinate treatment of shared risk factors (e.g., glycemic control in diabetic patients)
- Consider shared decision-making for aggressive cardiovascular prevention
3. The Eye-Cardiovascular Connection Extends Beyond NVG
While NVG presents the strongest signal, other retinal vascular diseases (e.g., retinal vein occlusion) may also warrant cardiovascular evaluation. Future research will clarify whether earlier intervention in these patients could improve outcomes.
What Patients Should Know
If you’ve been diagnosed with NVG or have risk factors for it (diabetes, hypertension, or retinal vascular disease), ask your eye care provider about:
- Your overall cardiovascular risk assessment
- Whether you need blood pressure, cholesterol, or blood sugar monitoring
- How to coordinate care between your ophthalmologist and primary doctor
Key Takeaway: NVG isn’t just about vision—it’s a systemic warning sign that demands attention from your entire care team.
Frequently Asked Questions
Q: Can NVG be prevented?
A: While NVG itself can’t always be prevented, controlling underlying conditions like diabetes, hypertension, and retinal vein occlusion can reduce risk. Regular eye exams are critical for early detection.
Q: Should all glaucoma patients be screened for cardiovascular disease?
A: Not necessarily. The strongest association is with NVG. However, patients with primary open-angle glaucoma and significant vascular risk factors (e.g., uncontrolled diabetes) may also benefit from cardiovascular evaluation.
Q: What’s the first step if I’m diagnosed with NVG?
A: Schedule a comprehensive eye exam to assess your glaucoma treatment options, and request a referral to your primary care physician or cardiologist for a full cardiovascular evaluation.
The Future: Bridging Eye Care and Cardiology
This study underscores the need for integrated care models where ophthalmologists and cardiologists collaborate more closely. Emerging research may identify:
- Biomarkers that predict which retinal patients are at highest cardiovascular risk
- Targeted therapies that address both ocular and systemic vascular dysfunction
- Guidelines for shared decision-making in high-risk patients
For now, the message is clear: when you see NVG, look beyond the eye.